Dr. Reddy's Auditor Reviews Q1 FY26 Interim Financials

Dr. Reddy's Laboratories Limited announced that Ernst & Young Associates LLP completed their review of the company's condensed consolidated interim financial statements for the three months ended June 30, 2026 and 2025. The auditors reported that they are not aware of any material modifications that should be made for the statements to conform with International Accounting Standard (IAS) 34. This follows an unqualified audit opinion issued on the company's consolidated financial statements as of March 31, 2026.